WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Bone Biologics Corporation (NASDAQ:BBLG), a developer of orthobiologic products for spine fusion, announced the pricing of an underwritten public offering of 3,777,778 units at an offering price of $1.35 per unit, for total gross proceeds of $5,100,000 before deducting underwriting discounts and commissions and other offering expenses.
Scotts Miracle-Gro Co. Reveals Fiscal 2023 & 4Q Results, Hawthorne Subsidiary Performance
Scotts Miracle-Gro Co. (NYSE: SMG) recently reported its results for the fourth quarter and fiscal year that ended September 30, 2023, including the results of its subsidiary Hawthorne Gardening Company, a provider of nutrients, lighting and other materials used in the indoor and hyd
